Trial NCT02661464

View at ClinicalTrials.gov 
Aliases: NCT02967003
Org. Study IDs: CR108112
Secondary IDs: 2015-004139-11 VAC52150EBL4001

Last trial update was posted on 2024-01-02

MeSH Interventions

Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic

MeSH Conditions

Hemorrhagic Fever, Ebola Hemorrhagic Fevers, Viral

Other Conditions


Stopping Reasons

Due to the pandemic with only one participant in follow up, as the impact on the safety was determined to be negligible, the study was terminated early.

Limitations And Caveats

As none of the participants met Cohort 2 eligibility criteria pre-specified in the protocol, therefore no participants were enrolled in Cohort 2. So the results were only presented for Cohorts 1 and 3.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID